Report ID: 10078330 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
Global Veterinary/Animal Vaccines Industry was valued at USD 6.60 Billion in the year 2017. Global Veterinary/Animal Vaccines Industry is further estimated to grow at a CAGR of 6.2 % from 2019 to reach USD 10.57 Billion by the year 2025. European region holds the highest Industry share in 2017 and Asia Pacific Industry is considered as the fastest growing Industry in the forecasted period. At a country level, Germany and France are projected to grow strongly in the coming years.
Major market players in Veterinary/Animal Vaccines Industry are Merck Animal Health, Boehringer Ingelheim, Bioniche Animal Health, Merial (Sanofi), Virbac, Zoetis (Pfizer), Bayer Healthcare, Elcano Animal Health, Hipra, China Animal Husbandry, and brief information of 10 companies will be provided in the report. Rising research and development expenses to address the changing demand of end users. Similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of the top players in the last 5 years.
SWOT Analysis of Veterinary/Animal Vaccines Industry:
Strength:
Increasing research and investments related activities
Rising Incidence of Zoonotic Diseases
Weakness:
Availability and high cost of the vaccine
Opportunities:
Technological advancements
Threats:
Government intervention in the distribution channel
The Global Veterinary/Animal Vaccines is segmented as by-products, by Technology, by diseases, and by region. On the basis of products, the Industry is segmented as Livestock Vaccines, Companion Animal Vaccines, Porcine Vaccines, Equine Vaccines, Poultry Vaccines, Aquaculture Vaccines and Other Animal Vaccines of which Porcine Veterinary/Animal Vaccines holds the highest Industry share. On the basis of technology Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines, Toxoid Vaccines, Recombinant Vaccines, DNA Vaccines, Conjugate Vaccines, Companies of which Live Attenuated Vaccines expected to form the largest technological segment.
Veterinary/Animal Vaccines Industry Segmentation:
By Technology
• Inactivated Vaccines
• Live Attenuated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• DNA Vaccines
• Conjugate Vaccines
By Diseases
• Poultry Diseases
• Companion Animal Disease
• Livestock Diseases
• Aquaculture Diseases
• Other Diseases
• Livestock Vaccines
• Companion Animal Vaccines
• Porcine Vaccines
• Equine Vaccines
• Poultry Vaccines
• Aquaculture Vaccines
• Other Animal Vaccines
By Region
• North America
o USA
o Canada
• Europe
o Germany
o U.K.
o France
o Italy
o Rest of Europe
• APAC
o China
o India
o Japan
o Rest of Asia-Pacific
• RoW
o Latin America
o Middle East & Africa
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10078330 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
